Parsec Financial Management, Inc. Novo Nordisk A S Transaction History

Parsec Financial Management, Inc.

$2.37 Billion
Q1 2023

A detailed history of Parsec Financial Management, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Parsec Financial Management, Inc. holds 234,871 shares of NVO stock, worth $30.8 Million. This represents 1.58% of its overall portfolio holdings.

Number of Shares

234,871

Previous 243,651 3.6%

Holding current value

$30.8 Million

Previous $33 Million 13.36%

% of portfolio

1.58%

Previous 1.47%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 06, 2023	SELL	$132.34 - $159.14 $1.16 Million - $1.4 Million	-8,780 Reduced 3.6%	234,871 $37.4 Million
Q4 2022 Feb 06, 2023	SELL	$102.55 - $135.33 $1.07 Million - $1.41 Million	-10,407 Reduced 4.1%	243,651 $33 Million
Q3 2022 Nov 07, 2022	SELL	$95.28 - $116.93 $1.74 Million - $2.14 Million	-18,295 Reduced 6.72%	254,058 $25.3 Million
Q2 2022 Jul 06, 2022	SELL	$103.24 - $121.81 $1.45 Million - $1.71 Million	-14,051 Reduced 4.91%	272,353 $30.3 Million
Q1 2022 May 09, 2022	SELL	$93.1 - $112.54 $569,492 - $688,407	-6,117 Reduced 2.09%	286,404 $31.8 Million
Q4 2021 Feb 08, 2022	SELL	$95.88 - $117.08 $280,257 - $342,224	-2,923 Reduced 0.99%	292,521 $32.8 Million
Q3 2021 Nov 10, 2021	BUY	$84.42 - $106.62 $339,115 - $428,292	4,017 Added 1.38%	295,444 $33.7 Million
Q2 2021 Jul 26, 2021	BUY	$67.66 - $84.76 $414,349 - $519,070	6,124 Added 2.15%	291,427 $24.4 Million
Q1 2021 Apr 23, 2021	SELL	$67.06 - $75.82 $796,270 - $900,286	-11,874 Reduced 4.0%	285,303 $19.2 Million
Q4 2020 Feb 03, 2021	SELL	$63.89 - $73.8 $607,274 - $701,469	-9,505 Reduced 3.1%	297,177 $20.8 Million
Q3 2020 Nov 06, 2020	SELL	$63.69 - $70.22 $963,757 - $1.06 Million	-15,132 Reduced 4.7%	306,682 $21.3 Million
Q2 2020 Aug 04, 2020	SELL	$58.54 - $67.94 $2.18 Million - $2.53 Million	-37,294 Reduced 10.39%	321,814 $21.1 Million
Q1 2020 May 08, 2020	SELL	$49.46 - $64.78 $1.34 Million - $1.76 Million	-27,109 Reduced 7.02%	359,108 $21.6 Million
Q4 2019 Jan 29, 2020	SELL	$49.86 - $58.26 $479,852 - $560,694	-9,624 Reduced 2.43%	386,217 $22.4 Million
Q3 2019 Oct 23, 2019	SELL	$47.54 - $53.43 $203,566 - $228,787	-4,282 Reduced 1.07%	395,841 $20.5 Million
Q2 2019 Jul 23, 2019	BUY	$46.79 - $52.47 $444,879 - $498,884	9,508 Added 2.43%	400,123 $0
Q1 2019 Apr 25, 2019	BUY	$46.36 - $52.63 $337,732 - $383,409	7,285 Added 1.9%	390,615 $20.4 Million
Q4 2018 Jan 29, 2019	BUY	$41.54 - $47.25 $194,324 - $221,035	4,678 Added 1.24%	383,330 $17.7 Million
Q3 2018 Oct 30, 2018	BUY	$46.76 - $51.24 $118,489 - $129,842	2,534 Added 0.67%	378,652 $17.9 Million
Q2 2018 Jul 26, 2018	BUY	$44.29 - $50.42 $245,720 - $279,730	5,548 Added 1.5%	376,118 $17.3 Million
Q1 2018 Apr 25, 2018	BUY	$48.49 - $58.14 $195,366 - $234,246	4,029 Added 1.1%	370,570 $18.3 Million
Q4 2017 Jan 26, 2018	BUY	$47.53 - $53.73 $47,339 - $53,515	996 Added 0.27%	366,541 $19.7 Million
Q3 2017 Oct 25, 2017	BUY	$41.15 - $49.22 $15 Million - $18 Million	365,545	365,545 $17.6 Million

Others Institutions Holding NVO

# of Institutions

1,988

Shares Held

318M

Call Options Held

5.23M

Put Options Held

4.97M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $296B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsec Financial Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Parsec Financial Management, Inc. with notifications on news.

Account

Parsec Financial Management, Inc. Novo Nordisk A S Transaction History